|
82%
agree
28 votes
|
AFLAC is growing its distribution and making operations more efficient |
|
100%
agree
7 votes
|
AFLAC is the leading company in its field and has a strong track record |
|
100%
agree
5 votes
|
Great Buy |
|
60%
agree
10 votes
|
Deceleration of growth in the U.S. |
|
22%
agree
9 votes
|
Low Japanese consumer confidence have slowed growth |
June 20, 2013
The American Family Life Assurance Company (AFLAC) (NYSE: AFL) sells medical and life insurance in the United States and Japan. 73% of the company's revenue comes from its Japanese segment, while the remaining 27% comes from its American operations.[1] In both segments, AFLAC focuses on offering supplemental coverage to people who may already have insurance from their employer or their government. AFLAC also offers customizable cancer insurance packages and different 'rider' policies that can be attached to an individual's insurance policy as a supplement for more specified coverage.
The investment portfolio of an insurance company is as important as ever in light of the crisis at the largest life insurer by market share, American International Group (AIG). On concern about AFLAC's portfolio exposure, the company's stock fell more than 30% in mid January, 2009. This was partially in response to losses in AFLAC's investment portfolio.
(Read more at Wikinvest
) 